Limin Group Co

Limin Group Co Equity

The The Equity of Limin Group Co (002734.SZ) as of Nov 19, 2026 is 3.96 B CNY. In the previous year, The Equity was 2.64 B CNY — a change of 49.87% (higher).

Equity

3.96 BCNY

YoY

49.87%

Last updated:

In 2025, Limin Group Co's equity was 3.96 B CNY, a 49.87% increase from the 2.64 B CNY equity in the previous year.

The Limin Group Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
1.82 B CNY
Jan 1, 2019
2.07 B CNY
Jan 1, 2020
2.37 B CNY
Jan 1, 2021
2.70 B CNY
Jan 1, 2022
2.80 B CNY
Jan 1, 2023
2.77 B CNY
Jan 1, 2024
2.64 B CNY
Jan 1, 2025
3.96 B CNY
The Limin Group Co Equity history
YEAREquityYoY
3.96 BCNY+49.87%
2.64 BCNY-4.71%
2.77 BCNY-0.90%
2.80 BCNY+3.59%
2.70 BCNY+14.07%
2.37 BCNY+14.36%
2.07 BCNY+14.01%
1.82 BCNY+8.63%
1.67 BCNY+5.32%
1.59 BCNY+105.95%
770.92 MCNY+52.43%
505.76 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Limin Group Co Stock analysis

What does Limin Group Co do? Limin Group Co., Ltd. generates revenue through the research, development, manufacture, and distribution of pesticides. The company offers germicide products like mancozeb, cymoxanil, fosetyl-aluminum, and pyrimethanil, alongside pesticides such as thiacloprid and herbicides including mesotrione. Its primary customers are agricultural businesses and distributors within domestic and international markets, with sales focused on both the Chinese market and overseas regions. The firm's product portfolio targets crop protection needs across various farming segments. The company's revenue streams are derived from the sale of its pesticide formulations, which include germicides, insecticides, and herbicides. Key products like mancozeb and mesotrione are distributed domestically and internationally, serving agricultural and horticultural sectors. Limin Group's business model relies on direct sales to agricultural enterprises and partnerships with distributors who handle regional distribution networks. Limin Group's market segments include domestic agricultural producers and international buyers seeking crop protection solutions. The firm's product range addresses specific pest control requirements, with germicides targeting fungal infections and herbicides managing weed growth. Sales are conducted through established distribution channels in China and abroad, ensuring consistent revenue from both local and global agricultural markets. Limin Group Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Limin Group Co's Equity

Limin Group Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Limin Group Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Limin Group Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Limin Group Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Limin Group Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Limin Group Co stock

The Equity of Limin Group Co is 3.96 B CNY in 2025.

The Equity of Limin Group Co changed from 2.64 B CNY to 3.96 B CNY, representing a 49.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Limin Group Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Limin Group Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Limin Group Co

All Key Metrics — Limin Group Co